XPan
The Living Force
Temporary stop of "Vaccinations" with Nuvaxovid below age of 30
2 Nov 2022
Still - I think what the Swedish Heath authorities write is cow - which i will highlight in the translated text below. They make myocarditis and pericarditis sound trivial and "will resolve by itself". WTF ?! And that of course, most people are being "vaccinated" with Pfizer anyway... [What could possibly go wrong] On top of that - how they blatantly recommended "simply to choose a different vaccine" as your next dose - like, 'Don't worry when you mix them'.
This is not Medicine. It is State & Pharma sponsored BS in my book.
2 Nov 2022
Still - I think what the Swedish Heath authorities write is cow - which i will highlight in the translated text below. They make myocarditis and pericarditis sound trivial and "will resolve by itself". WTF ?! And that of course, most people are being "vaccinated" with Pfizer anyway... [What could possibly go wrong] On top of that - how they blatantly recommended "simply to choose a different vaccine" as your next dose - like, 'Don't worry when you mix them'.
This is not Medicine. It is State & Pharma sponsored BS in my book.
Vaccinationer med Nuvaxovid pausas för personer 30 år och yngre
Folkhälsomyndigheten rekommenderar att det proteinbaserade covid-19-vaccinet Nuvaxovid inte ges till personer som är 30 år och yngre. Beslutet är temporärt och gäller från och med den 2 november 2022.
www.folkhalsomyndigheten.se
Vaccinations with Nuvaxovid paused for people 30 years and younger
The Public Health Agency recommends that the protein-based covid-19 vaccine Nuvaxovid should not be given to people aged 30 and under. The decision is temporary and will apply from 2 November 2022.
The decision is based on reports of an increased risk of myocarditis and pericarditis. Data from Australia indicate an increased incidence, particularly in younger people, associated with vaccination with Nuvaxovid. The recommendation is made on the basis of precaution and is valid until more information is available from the ongoing studies. The vaccine can continue to be given as a primary or booster dose to individuals 31 years and older.
- We are closely monitoring the situation and awaiting more data. However, anyone who is younger and recently vaccinated with Nuvaxovid need not be concerned. The risk is very low and you can continue with the next dose with another vaccine," says Sören Andersson, Head of the Vaccination Programme Unit.
Nuvaxovid has not been widely used in Sweden. The total number of doses is around 7 000. The current vaccine for people under the age of 31 is Comirnaty, from Pfizer/BioNTech.
Both myocarditis and pericarditis often resolve on their own, without causing any lasting symptoms, but suspected symptoms should be assessed by a doctor, for example at a health centre or emergency department. Medical treatment and hospital monitoring may be required for confirmed cases.